Vatnikas
voted
Hey, mooers!
Were you tuned into our "Invest with Sarge" livestream which demystifies the art of trending stocks? If not, no worries — we've got a balanced recap to keep you in the loop and ready to tackle the market trends like a pro!
Insights into Trending Stocks
In our recent session, Sarge explored the dynamics of trending stocks such as $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$. These stocks often gain significant attention and can present opportunitie...
Were you tuned into our "Invest with Sarge" livestream which demystifies the art of trending stocks? If not, no worries — we've got a balanced recap to keep you in the loop and ready to tackle the market trends like a pro!
Insights into Trending Stocks
In our recent session, Sarge explored the dynamics of trending stocks such as $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$. These stocks often gain significant attention and can present opportunitie...
65
13
Vatnikas
commented on
$BioVie (BIVI.US)$
CARSON CITY, Nev., Sept. 23, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants ("Pre-Funded Warrants") in lieu thereof) and accomp...
CARSON CITY, Nev., Sept. 23, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants ("Pre-Funded Warrants") in lieu thereof) and accomp...
3
Vatnikas
commented on
$BioVie (BIVI.US)$
NEWS
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...
NEWS
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...
1
2
Vatnikas
reacted to
$BioVie (BIVI.US)$ BIV201 Phase 3 is pending funds from “undisclosed yet partner” , partner is dragging their feet and not in a hurry to cut the check due economy , covid and ukraine bull. Especially if that undisclosed yet partner is looking to buy out Biovie , thus intrested to buy BIVI shares at cheap.
The good news will when partnership and BIV201 Phase 3 funding will be announced
The good news will when partnership and BIV201 Phase 3 funding will be announced
4
Vatnikas
commented on
$BioVie (BIVI.US)$ Holding @ 1.3. When is the next PR? Its in pathetic state seriously….
6
Vatnikas
commented on